Atria Investments, Inc - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 2 filers reported holding ALBANY MOLECULAR RESH INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Atria Investments, Inc ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q2 2017$350,000
+41.1%
16,137
-8.7%
0.02%
+31.2%
Q1 2017$248,000
-16.8%
17,670
+11.2%
0.02%
-30.4%
Q4 2016$298,00015,8880.02%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q3 2017
NameSharesValueWeighting ↓
Permian Investment Partners, LP 1,360,899$30,035,00018.46%
Healthcare Value Capital, LLC 498,200$10,995,00010.61%
Incline Global Management LLC 515,923$11,386,0003.41%
Wood Investment Counsel LLC 733,328$16,185,0002.42%
Netols Asset Management, Inc. 395,343$8,725,0001.66%
HealthCor Management, L.P. 1,400,000$30,898,0001.59%
Evercore Wealth Management, LLC 1,307,280$28,851,0001.44%
BRIDGER MANAGEMENT, LLC 813,934$17,964,0001.22%
ISZO CAPITAL MANAGEMENT LP 103,300$2,280,0001.16%
SEVEN LOCKS CAPITAL MANAGEMENT LP 351,437$7,756,0001.10%
View complete list of ALBANY MOLECULAR RESH INC shareholders